The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma

Medical Science Monitor

Volumn 11, Issue 5, 2005, Pages

  Reyes Ortiz, Carlos A ^a   Goodwin, James S ^a   Freeman, Jean L ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Cancer epidemiology; Health disparity; Melanoma; Socioeconomic status

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CANCER THERAPY; CAUCASIAN; CLINICAL TRIAL; EDUCATION; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; INCIDENCE; MASS SCREENING; MEDICAL LITERATURE; MELANOMA; META ANALYSIS; OUTCOMES RESEARCH; RADIATION EXPOSURE; REVIEW; RISK FACTOR; SOCIAL STATUS; SOCIOECONOMICS; SURVIVAL RATE; SYSTEMATIC REVIEW;

HUMANS; MELANOMA; NEOPLASM STAGING; RISK FACTORS; SKIN NEOPLASMS; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 20344386246     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Parkin DM, Whelan SL, Ferlay J et al (Eds): Cancer incidence in five continents Vol. VIII. IARC Scientific Publications No. 155, Lyon, France: International agency for Research on Cancer, 2002
2. Marrett LD, Nguyen HL, Armstrong BK: Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer, 2001; 92: 457-62
3. Martin RCW. Robinson E: Cutaneous melanoma in Caucasian New Zealanders: 1995-1999. ANZ J Surg, 2004; 74: 233-37
4. MacKie RM, Bray CA, Hole DJ et al: Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet, 2002; 360: 587-91
5. Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE et al: Trends in mortality from malignant melanoma in Sweden, 1970-1996. Cancer, 2000; 89: 348-55
6. Crocetti E, Capocaccia R. Casella C et al: Population-based incidente and mortality cancer trenes (1986-1997) from the network of Italian cancer registries. Eur J Cancer Prev, 2004; 13: 287-95
7. Wingo PA, Ries LAG, Rosenberg HM et al: Cancer incidence and mortality, 1973-1995. Cancer. 1998; 82: 1197-207
8. Jemal A, Devesa SS, Hartge P, Tucker MA: Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst, 2001; 93: 678-83
9. Geller AC, Miller DK, Annas GD, Demiere MF: Melanoma incidence and mortality among US Whites, 1969-1999. JAMA. 2002; 288: 1719-20
10. Rogers GS, Braun SM: Prognostic factors. Dermatol Clin, 2002; 20: 647-58
11. Koh HK, Geller AC: Melanoma and skin cancer control: an international perspective. Cancer Control. 1995; 2: 385-91
12. st century. CA Cancer J Clin, 2000; 50: 215-36
13. Marks R: Epidemiology of melanoma. Clin Exp Dermatol, 2000; 25: 450-63
14. de Vries E, Coebergh JW: Cutaneous malignant melanoma in Europe. Eur J Cancer, 2004; 40: 2355-66
15. Rafnsson V, Hrafnkelsson J, Tulinius H et al: Risk factors for malignant melanoma in an Icelandic population sample. Prev Med, 2004; 39: 247-52
16. Gandini S, Sera F, Cattaruzza MS et al: Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer, 2005; 41: 45-60
17. National Cancer Institute. Cancel health disparities, 2002. http://www.uci.nih.gov/newscenter/healthdisparites
18. De Vries E, Boniol M, Dore JF, Coebergh JWW and EUROCARE working group: Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. Eur J Cancer, 2004; 40: 1045-52
19. Berkman LF, Macintyre S: The measurement of social class in health studies: old measures and new formulations. In: Kogevinas M, Pearce N, Susser M, Boffetta P, editors. Social inequalities and cancer, IARC Scientific Publications No. 138. Lyon, France: International Agency for Research on Cancer, 1997, 51-64
20. Lynch JW, Kaplan GA: Socioeconomic position. In: Berknian LF. Kawachi I, editor. Social epidemiology. New York: Oxford University Press; 2000, 13-35
21. Krieger N, Quesenberry C, Peng T et al: Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, black, Hispanic, and white residents of the San Francisco Bay Area, 1988-92 (United Sates). Cancer Causes Control, 1999; 10: 523-37
22. Berrino F, Gipocaccia R, Esteve J et al: (Eds): Survival of cancer patients in Europe: the EUROCARE-2 Study. IARC Scientific Publication No. 151. Lyon, France: International Agency for Research on Cancer, 1999
23. Hiatt RA: The social determinants of cancer. Eur J Epidemiol, 2004; 19: 821-22
24. Mackillop WJ, Zhang-Salomons J, Boyd CJ, Groome PA: Associations between community income and cancer incidence in Canada and the United States. Cancer, 2000; 89: 901-12
25. Schrijvers CTM, Mackenbach JP, Lutz J-M et al: Deprivation, stage at diagnosis and cancer survival. Int J Cancer, 1995; 63: 324-29
26. Kogevinas M, Marmot MG, Fox AJ, Goldblatt PO: Socioeconomic differences in cancer survival. J Epidemiol Comm Health, 1991; 45: 216-19
27. Stellman SD, Resnicow K; Tobacco smoking, cancer and social class. In: Kogevinas M, Pearce N, Susser M, Boffetta P (Eds). Social inequalities and cancer. IARC Scientific Publications No. 138. Lyon. France: International Agency for Research on Cancer; 1997, 229-50
28. Berwick M: Why are people still dying from melanoma? Arch Dermatol, 1999; 135: 1534-36
29. Vagero D, Persson G: Risks, survival and trends of malignant melanoma among white and blue collar workers in Sweden. Soc Sci Med, 1984; 19: 475-78
30. : Gallagher RP, Elwood JM, Threlfall WJ et al: Socioeconomic status, sunlight exposure, and risk of malignant melanoma: the Western Canada Melanoma Study. J Natl Cancer Inst. 1987; 79: 647-52
31. Rimpela AH, Pucala EI: Cancers of affluence: positive social class gradient and rising incidence trend in some cancer forms. Soc Sci Med., 1987; 24: 601-6
32. Bonett A, Roder A, Esterman A: Epidemiological features of melanoma in South Australia: implications for cancer control. Med J Aust, 1989; 151: 502-9
33. Elwood JM, Whitehead SM. Davison J et al: Malignant melanoma in England: risks associated with naevi, freckles, social class, hair color, and sunburn. Int J Epidemiol, 1990; 19: 801-10
34. Kirkpatrick CS, Lee JA, White E: Melanoma risk by age and socio-economic status. Int J Cancer, 1990; 46: 1-4
35. Williams J, Clifford C, Hopper J, Giles G: Socioeconomic status and cancer mortality and incidence in Melbourne. Eur J Cancer, 1991; 27: 917-21
36. Lee PY, Silverman MK, Rigel DS et al: Level of education and the risk of malignant melanoma. J Am Acad Dermatol, 1992; 26: 59-63
37. Dosemeci M, Hayes RB, Vetter R et al: Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey. Cancer Causes Control, 1993; 4: 313-21
38. White E, Kirkpatrick CS, Lee JAH: Case-control study of malignant melanoma in Washington. Am J Epidemiol, 1994; 139: 857-68
39. Pion LA, Rigel DS. Garfinkel L et al: Occupation and the risk of malignant melanoma. Cancer, 1995; 75(Suppl,2): 637-44
40. Goodman KJ, Bible ML, London S, Mack TM: Proportional melanoma incidence and occupation among white males in Los Angeles County (California, United States). Cancer Causes Control, 1995; 6: 451-39
41. Aase A, Bentham G: Gender, geography and socio-economic status in the diffusion of malignant melanoma risk. Soc Sci Med., 1996; 42: 1621-37
42. Mackie RM, Hole DJ: Incidence and thickness of primary tumors and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status. Br Med J, 1996; 312: 1123-28
43. Smith D, Taylor R, Coates M: Socioeconomic differentials in cancer incidence and mortality in urban New South Wales, 1987-1991. Aust N Z J Public Health, 1996; 20: 129-37
44. Austin DF, Reynolds P: Investigation of an excess of melanoma among employees of the Lawrence Livermore National Laboratory. Am J Epidemiol, 1997; 145: 324-35
45. Burnley IH: Disadvantage and male cancer incidence and mortality in New South Wales 1985-1993. Soc Sci Med., 1997; 45: 465-76
46. Gorey KM, Holowaty EJ, Laukkanen E et al: Association between socioeconomic status and cancer incidence in Toronto, Ontario: possible confounding of cancer mortality by incidence and survival. Cancer Prev Control, 1998; 2: 236-41
47. Harrison RA, Haque AU, Roseman JM, Soong SJ: Socioeconomic characteristics and melanoma incidence. Ann Epidemiol, 1998; 8: 327-33
48. Bouchardy C, Schuler G, Minder C et al. Cancer risk by occupation and socioeconomic group among men - a study by The Association of Swiss Cancer Registries. Scand J Work Environ Health, 2002; 28(Suppl.1): 1-88
49. Hermninki K, Li X: Level of education and the risk of cancer in Sweden. Cancer Epidemiol Biomark Prev, 2003; 12: 796-802
50. Hemminki K, Zhang H, Czene K: Socioeconomic factors in cancer in Sweden. Int J Cancer, 2003; 105: 692-700
51. Travier N, Gridley G, Blair A et al: Cancer incidence among male Swedish veterinarians and other workers of the veterinary industry: a recor-linkage study. Cancer Causes Control, 2003; 14: 587-93
52. Perez-Gomez B, Pollan M, Gustavsson P et al: Cutaneous melanoma: hints from occupational risks by anatomic site in Swedish men. Occup Environ Med, 2004; 61: 117-26
53. Ocana-Riola R. Sanchez-Cantalejo C, Rosell J et al: Socioeconomic level, farming activities and risk of cancer in small areas of Southern Spain, Europ J Epidemiol, 2004; 19: 643-50
54. Bevona C, Sober AJ: Melanoma incidence trends. Dermatol Clin, 2002; 20: 589-93
55. Magnus K: The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer, 1991; 47: 12-19
56. Garbet C, McLeod GRC, Buettner PG: Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer, 2000; 89: 1269-78
57. Koh HK, Geller AC, Miller DR et al: Who is being screened for melanoma/skin cancer? Characteristics of persons screened in Massachusetts. J Am Acad Dermatol, 1991; 24(2 Pt 1): 271-77
58. Girgis A, Campbell EM, Redman S et al: Screening for melanoma: a community survey of prevalence and predictors. Med J Aust, 1991; 154: 338-43
59. Saraiya M, Hall HI, Thompson T et al: Skin cancel screening among US adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med, 2004; 39: 308-14
60. Dennis LK: Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 Surveillance. Epidemiology, and End Results program registry. Arch Dermatol, 1999; 135: 275-80
61. Shaw HM, McGovern VJ, Milton GW, Farago GA: Cutaneous malignant melanoma: occupation and prognosis. Med J Aust, 1981; 1: 37-38
62. Roder DM, Like CG, McCaul KA, Esterman AJ: Trends in prognostic factors of melanoma in South Australia, 1981-1992: implications for health promotion. Med J Aust, 1995; 162: 25-29
63. Geller AC, Miller DR, Lew RA et al: Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts. Am J Public Health, 1996; 86: 538-44
64. Chang AE, Kamell LH, Menck HR: The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer, 1998; 83: 1664-78
65. Roetzheim RG, Pal N, Tennant C et al: Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst, 1999; 91: 1409-15
66. Epstein D, Lange JR, Gruber SB et al: Is physician detection associated with thinner melanomas? JAMA, 1999; 281: 640-43
67. Van Durme DJ, Ferrante JM, Pal N et al: Demographic predictors of melanoma stage at diagnosis. Arch Fam Med. 2000; 9: 606-11
68. Roetzheim RG, Pal N, Van Durme DJ et al: Increased supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection, J Am Acad Dermatol. 2000; 43: 211-18
69. Singh GK, Miller BA, Hankey BF, Edwards BK (Eds): Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999. NCI Cancer Surveillance Monograph Series, Number 4. NIH Publication No. 03-5417. Bethesda, MD: National Cancer Institute, 2003
70. Carli P, De Giorgi V, Palli D et al: Patterns of detection of superficial spreading and nodular-type melanoma: A multicenter Italian study. Dermatol Surg, 2004; 30: 1371-76
71. Cress RD, Holly EA: Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and Blacks: An analysis of California cancer registry data, 1988-93. Cancer Causes Control, 1997; 8: 246-52
72. Byrd KM, Wilson DC, Hoyler SS, Peck GL: Advanced presentation of melanoma in African Americans. J Am Acad Dermatol, 2004; 50: 21-24
73. Hemmings DE, Jolmson DS, Tominaga GT, Wong JH: Cutaneous melanoma in a multiethnic population. Arch Surg, 2004; 139: 968-73
74. Miller DR, Geller AC, Wyatt SW et al: Melanoma awareness and self-examination practices: results of a United States survey. J Am Acad Dermatol, 1996; 34: 962-70
75. Temoshok L, Diclemente RJ, Sweet DM et al. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer, 1984; 54: 3048-53
76. MacKie RM, Bray GA, Leman JA: Effect of public education aimed at early diagnosis of malignant melanoma: cohort comparison study. BMJ, 2003; 326: 367
77. Nagore E, Oliver V, Moreno-Picot S, Fortea JM: Primary cutaneous melanoma in hidden sites is associated with thicker tumours- a study of 829 patients. Eur J Cancer, 2001; 37: 79-82
78. Bellows CF, Belafsky P, Fortgang IS. Beech DJ: Melanoma in African-Americans: trends in biological in behavior and clinical characteristics over two decades. J Surg Oncol, 2001; 78: 10-16
79. Hemo Y, Gutman M, Klausner JM: Anatomic site of primary melanoma is associated with depth of invasion. Arch Surg, 1999; 134: 148-50
80. Richard MA, Grob JJ, Avril MF et al: Melanoma and tumor thickness. Challenges of early diagnosis. Arch Dermatol, 1999; 135: 269-74
81. Sant M and the EUROCARE Working Group: Overview of the EUROCARE-2 results on survival of cancer patients diagnosed in 1985-1989. In Berrino F. Capocaccia R, Esteve J et al (Eds). Survival of cancer patients in Europe: the EUROCARE-2 Study. IARC Scientific Publication No. 151. Lyon, France: International Agency for Research on Cancer, 1999, 525-41
82. Luke CG, Coventry BJ, Foster-Smith EJ. Roder DM: A critical analysis of reasons for improved survival from invasive cutaneous melanoma. Cancer Causes Control, 2003; 14: 871-78
83. Coleman NP, Rachet N, Woods LM: Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer, 2004; 90: 1367-73
84. Gorey KM, Holowaty EJ, Cordon F et al.: An inter national comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas. Am J Public Health, 1997; 87: 1156-63
85. Boyd C, Zhang-Salomons JY, Groome PA, Mackillop WJ: Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol, 1999; 17: 2244-55
86. Auvinen A, Karjalainen S: Possible explanations for social class differences in cancer patient survival. In: Kogevinas M, Pearce N, Susser M, Boffetta P, (Eds). Social inequalities and cancer, IARC Scientific Publications No. 138. Lyon, France: Intel national Agency for Research on Cancer, 1997, 377-97
87. Bradley CJ, Given CW, Roberts C: Disparities in cancer diagnosis and survival. Cancer, 2001; 91; 178-88
88. Simon MS, Severson RK: Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer, 1996; 77: 215-38
89. Cella DF, Orav EJ, Kornblith AB et al: Socioeconomic status and cancer survival. J Clin Oncol, 1991; 9: 1500-9
90. Schrijvers CT, Coebergh JW, van der Heijden LH. Mackenbach JP: Socioeconomic variation in cancer survival in the southeastern Netherlands, 1980-1989. Cancer, 1995; 75: 2946-53
91. Levi F, Randimbison L, La Vecchia C et al: Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland. Int J Cancer, 1998; 78: 315-19
92. Woods LM, Rachet B, Riga M et al: Geographical variation in life expectancy at birth in England and Wales is largely explained by deprivation. J Epidemiol Community Health, 2005; 59: 115-20
93. Coates A. Thomson D, McLeod GRM et al: Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer, 1993; 29A: 1731-34